Digital Genome Market Scope And Analysis

  • Report Code : TIPBT00002181
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Digital Genome Market Analysis and Scope (2023 to 2031)

Buy Now


Digital Genome Market Report Scope

Report Attribute Details
Market size in 2023 US$ 20.12 Billion
Market Size by 2031 US$ 69.12 Billion
Global CAGR (2023 - 2031) 16.7%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Product
  • DNA/RNA Analysis
  • Sequencing Chips
  • Sequencing and Analyzer Instruments
  • Sample Prep Instruments
  • Sequencing and Analysis Software
By Application
  • Diagnostics
  • Agricultural
  • Academic Research
  • Drug Discovery
  • Personalizes Medicine
  • Others
By End User
  • Diagnostics and Forensic Labs
  • Academic Research Institutes
  • Hospitals
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • THERMO FISHER SCIENTIFIC INC
  • F HOFFMANN LA ROCHE LTD
  • Illumina Inc
  • QIAGEN
  • GenomeMe Inc
  • NanoString Technologies Inc
  • BD
  • bioMerieux SA
  • GenMark Diagnostics Inc
  • Perkin Elmer Inc
  •  

    Digital Genome Market News and Recent Developments

    The digital genome market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for innovations, business expansion, and strategies:

    • In Janurary 2023, QIAGEN Digital Insights (QDI) launched QIAGEN CLC Genomics Workbench Premium that removes the data-analysis bottleneck of next-generation sequencing (NGS) by to analyze and interpret whole genome sequencing (WGS), large panel sequencing data, and whole exome sequencing (WES). (Source: QIAGEN, Press Release)
    • In August 2022, Mount Sinai Health System and the Icahn School of Medicine launched a new human genome sequencing research project called as Mount Sinai Million Health Discoveries Program with the Regeneron Genetics Center (RGC). Goal is to provide unique data set to researchers that will help them assess the true potential of genetics-based, precision medicine approaches to guide everyday patient care. (Source: Mount Sinai Health System, Newsletter)

    Digital Genome Market Report Coverage and Deliverables

    The “Digital Genome Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:

    • Digital genome market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Digital genome market trends
    • Detailed PEST and SWOT analysis
    • Digital genome market analysis covering key market trends, Global and regional framework, major players, regulations, and recent market developments
    • Digital genome industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles